Chemical inhibitors of cortexin 3 can exert their influence through various mechanisms that impinge upon the protein's function within neuronal cells. Alsterpaullone, known for its ability to disrupt cell cycle kinases, indirectly inhibits cortexin 3 by modulating cellular proliferation and differentiation processes that are essential for the maintenance and function of neurons. This can lead to a reduced activity of cortexin 3, which is believed to play a role in neuronal activity regulation. Similarly, LY294002 and Wortmannin, both phosphoinositide 3-kinase (PI3K) inhibitors, can interrupt the PI3K/Akt signaling pathway, a crucial route for neuroprotection and neuroplasticity, thereby possibly dampening cortexin 3's functional role. Furthermore, the inhibition of the p38 MAP kinase by SB203580 could disrupt the MAPK signaling pathway, which is vital for cellular stress responses, potentially affecting cortexin 3's role in the brain's response to various stimuli.
Additionally, PD98059 and U0126, both inhibitors of MEK, can affect the ERK/MAPK signaling pathway, which is integral to neuronal differentiation and plasticity. Since cortexin 3 is postulated to be involved in these areas, the inhibition of this pathway can indirectly impact its activity. Rapamycin, an inhibitor of the mTOR pathway, affects cell growth and protein synthesis, processes which cortexin 3 could influence within the neural context. Spautin-1 and SL327 both target aspects of the PI3K/Akt and MEK/ERK pathways, respectively, further elucidating the indirect methods by which cortexin 3 activity can be inhibited. ZM336372, a RAF kinase inhibitor, and Roscovitine, a cyclin-dependent kinase inhibitor, also alter signaling cascades such as the RAF/MEK/ERK pathway and cell cycle regulation, which could have implications for cortexin 3's role in neuronal development and function. Lastly, Lestaurtinib, by inhibiting tyrosine kinases, could indirectly alter signaling pathways involved in cell differentiation and survival, further influencing the activity of cortexin 3 in the brain.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $67.00 $306.00 | 2 | |
Alsterpaullone, a known inhibitor of cyclin-dependent kinases, can indirectly inhibit cortexin 3 by disrupting cell cycle progression, which cortexin 3 is potentially involved in due to its neuronal activity regulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a phosphoinositide 3-kinase inhibitor that can indirectly inhibit cortexin 3 by altering the PI3K/Akt signaling pathway, which is involved in neuronal survival and function, processes that cortexin 3 may be a part of. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a p38 MAP kinase inhibitor that can indirectly inhibit cortexin 3 by affecting the MAPK signaling pathway, which is critical for cellular stress responses and could impinge upon cortexin 3's functional role in the brain. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 inhibits MEK, which in turn inhibits ERK/MAPK signaling. This pathway is integral to neuronal function and plasticity, potentially affecting cortexin 3's role in these processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a PI3K inhibitor that can indirectly inhibit cortexin 3 by disrupting the PI3K/Akt pathway, which is significant in neuroprotection and neuroplasticity, potentially affecting cortexin 3's function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in cell growth and protein synthesis. Since cortexin 3 is associated with neuronal activity, inhibiting mTOR can indirectly affect its functional role. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $165.00 | ||
Spautin-1 promotes the degradation of PI3K, indirectly inhibiting cortexin 3 by impacting the PI3K/Akt pathway, crucial for neuronal survival wherein cortexin 3 might be involved. | ||||||
SL-327 | 305350-87-2 | sc-200685 sc-200685A | 1 mg 10 mg | $107.00 $332.00 | 7 | |
SL327 is an inhibitor of MEK, which indirectly can inhibit cortexin 3 by altering the ERK pathway, involved in neuronal plasticity and functions potentially linked with cortexin 3. | ||||||
ZM 336372 | 208260-29-1 | sc-202857 | 1 mg | $46.00 | 2 | |
ZM336372 is a RAF kinase inhibitor that can indirectly inhibit cortexin 3 by influencing the RAF/MEK/ERK signaling cascade, which is implicated in neuronal development and function, processes that cortexin 3 is potentially part of. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
Roscovitine is a cyclin-dependent kinase inhibitor, which can indirectly inhibit cortexin 3 by affecting cell cycle regulation, a process in which cortexin 3 could play a role in neuronal cells. |